Here’s an application for identifying regions of immune activity and infiltration in breast tumor tissue, defining the highly heterogeneous nature of breast cancer. Samples were stained with a 41-marker #immunooncology panel, acquired with whole slide imaging on Hyperion XTi™.
Some of our experts will be at #ESMOImmuno23 ESMO - Eur. Oncology in Geneva, starting tomorrow! 🥼🩺👩🔬Do not miss them!
Johanna Joyce Solange Peters George Coukos #AndreasHottinger #johnhaanen
CHUV / Centre hospitalier universitaire vaudois Université de Lausanne
#immunooncology #cancer #immunotherapy
We are excited to share a major milestone in CRI iAtlas: the addition of 2 datasets with single-cell RNA-seq and analysis modules! #immunoOncology #singlecell #RNAseq
Get to know the Immatics story and how we aim to deliver the power of T cells to #cancer patients through our scientific publications. Access a selection of our scientific content here: immatics.com/publications/
#healthcare #immunooncology #biotechnology #scientificpublications
From our #Boston #UserGroupMeeting last fall, here is a sneak peek into the presentation from Kathleen Pfaff, PhD, Principal Scientist Dana-Farber.
She presented on the topic of Quantitative #Multiplex #Assays for Pan-Cancer #ImmunoOncology Studies. bit.ly/42p7RMd
Join the discussion at our Immuno-Oncology Roundtable Xchange in #SanDiego Feb 27. More info at hub-xchange.com/immuno-oncolog…. Open to Senior Scientists in the #pharmaceutical / #biotech industry. #lifesciences #genomics #immunotherapy #immunooncology #oncology #biomarkers #celltherapies
IOTECH aspires to provide a forum for today's leaders in the field of #ImmunoOncology .
We welcome:
➡️pre-clinical/clinical studies
➡️solid/haematological cancers
➡️technological advances that decipher & improve clinical outcomes
Get in touch today!
Is anyone currently working on DUBs and cancer inflammation? This research topic IJMS MDPI I am helping to edit might be of interest to you. Please, do not hesitate to message me if interested. #ubiquitin #cancerinflammation #deubiqutinases #Immunotherapy #immunooncology
Live from our Cancer Research Institute Seminar Series: Andrea Bullock, MD, MPH BIDMC Department of Medicine + hosted by Taru Muranen 🇺🇦 “Turning Up the Heat: Expanding ImmunoOncology Responses in Cold #GI Malignancies” 🔥 #MedTwitter #CancerResearch
On May 15 at 12:00 pm ET, Rachel Karchin Johns Hopkins Medicine will discuss the application of #AI in #immunotherapy target discovery during an National Cancer Institute & Society for Immunotherapy of Cancer computational #ImmunoOncology webinar: sitcancer.org/education/webi…
Excited to share our lab's work on #computational #ImmunoOncology , #translating #data to #care #MCBIOS2024 !
We discussed our #data science discovery model from #cloud to #bench2 to #bedside , improving outcome #immunotherapy Translational Immuno-Informatics Lab (TIIL) Jason Luke, MD, FACP UPMC Hillman Cancer Center PittDeptofMed
It's Day 2 of #Immuno2024 ! 🎉 Come chat with us about how our PKPD & QSP modelling expertise can inform and de-risk the development of the next generation of IO drugs. Contact [email protected]. #PYC Oxford Global #biotech #pharma #drugdevelopment #immunooncology
We had a blast at the Lorne Cancer Conference Conference 2024 💥
Thank you to the researchers for sharing their experiences with us & discussing how RASTRUM can accelerate #CancerResearch . It's been a wonderful time connecting with you!
#3Dcellmodels #3Dcellculture #immunooncology
Learn how IQVIA Biotech tackles unique challenges in immuno-oncology (IO) trials, guiding biotechs to advance cancer treatments.
bit.ly/3w7jKLh
#ImmunoOncology #clinicalresearch
On May 15 at 12:00 pm ET, Rachel Karchin Johns Hopkins Medicine will discuss the application of #AI in #immunotherapy target discovery during an National Cancer Institute & Society for Immunotherapy of Cancer computational #ImmunoOncology webinar: sitcancer.org/education/webi…
Join us at the #IOTNCapstoneMeeting on May 14 – 15 to learn about scientific accomplishments in #ImmunoOncology across the IOTN Moonshot network. Additional information and registration can be found at events.cancer.gov/dcb/iotncapsto…. #CancerMoonshot
Our work for this underserved patient group continues the fight. geovax.com
#immunooncology #cancer #headandneckcancer #clinicaltrials
Today at #Immuno2024 , MP Sr. Scientist Natalia Venetz will present on #DARPins as a novel therapeutic modality, discussing conditionally activated DARPin therapeutics for #immunooncology , MP0533 and Switch-DARPin.
More: bit.ly/49SH4dw
Oxford Global
